Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Orelabrutinib |
Trade Name | |
Synonyms | ICP-022|ICP022|ICP 022 |
Drug Descriptions |
Orelabrutinib (ICP-022) inhibits BTK, potentially resulting in decreased growth of BTK-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | 1655504-04-3 |
NCIT ID | C156173 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Orelabrutinib | Orelabrutinib | 0 | 1 |